Oldipyong 5/20/12.5 mg

Adult dose

This medication is taken once daily, one tablet, with or without food, preferably at the same time each day (e.g., in the morning). The recommended dosing is as follows: - 5/20/12.5 mg: given to patients whose blood pressure is not adequately controlled with amlodipine/olmesartan medoxomil 5/20 mg combination therapy. - 5/40/12.5 mg: given when blood pressure is not adequately controlled with amlodipine/olmesartan medoxomil 5/40 mg.

Child dose

Safety and efficacy in pediatric patients under 18 years of age have not been established, so administration of this medication is not recommended.

This medication should be discontinued immediately if pregnancy occurs, as its use during the second and third trimesters can cause serious harm to the fetus and newborn. Patients with allergies or hypersensitivity to any ingredients in this medication or to similar classes of medications should not take it. It is also advisable for pregnant and nursing women not to use this medication. Patients with severe hypotension, severe valvular heart disease, unstable heart failure after acute myocardial infarction, or severe renal or hepatic impairment should not take this medication. In patients with decreased blood volume or electrolyte imbalance, hypotension may occur; therefore, careful monitoring of the patient's condition before administration and during treatment is necessary. Patients with poor renal function, kidney transplant patients, patients with renovascular hypertension, and those with impaired liver function may experience changes in renal and liver function, so regular check-ups are required during treatment. As this medication lowers blood pressure, dizziness or orthostatic hypotension may occur, and caution is needed when driving or operating hazardous machinery. This medication may interact with various other drugs; therefore, especially when taking lithium, NSAIDs, other antihypertensive drugs, or alcohol, consultation with a doctor or pharmacist is necessary. During the use of this medication, it is advisable to regularly check electrolyte levels and renal function through blood tests; if any unusual symptoms occur, inform healthcare professionals immediately. Photosensitivity may occur, so avoid excessive exposure to sunlight or ultraviolet rays. If any skin rash or itching develops, discontinue use and seek advice. In cases of overdose, severe hypotension or cardiac arrhythmias may occur, so it is important to adhere to the prescribed dosage and visit the hospital immediately if there are any suspicious symptoms. Safety and efficacy in children and adolescents under 18 years of age have not been established; therefore, use in these populations is not recommended. In the elderly, renal and liver functions may be impaired; hence, treatment should start with a lower dose and be closely monitored.

Serious side effects

Hives, severe swelling (edema), difficulty breathing, chest tightness, respiratory distress, cold sweat, pallor, high fever with severe rash, blisters, skin peeling, pain in mucous membranes of the mouth/eyes, yellowing of skin or eyes (jaundice), extreme lethargy, sudden and severe headache, thunderclap headache, seizures, confusion, visual disturbances, paralysis, markedly decreased urine volume, severe generalized edema with increased blood pressure.

Mild side effects

• Peripheral edema
• headache
• dizziness
• upper respiratory tract infections
• nasopharyngitis
• urinary tract infections
• sialadenitis
• leukopenia
• thrombocytopenia
• bone marrow suppression

This medication should be stored in a tightly sealed container to prevent exposure to air or moisture. The storage temperature should be maintained between 1 degree and 30 degrees Celsius.

Appearance

White and orange round film-coated tablets

Package unit

30 tablets (10 tablets/Alu-Alu X 3)